Evaluating the effects of an exercise program (Staying UpRight) for older adults in long-term care on rates of falls: study protocol for a randomised controlled trial.


Journal

Trials
ISSN: 1745-6215
Titre abrégé: Trials
Pays: England
ID NLM: 101263253

Informations de publication

Date de publication:
08 Jan 2020
Historique:
received: 29 09 2019
accepted: 02 12 2019
entrez: 10 1 2020
pubmed: 10 1 2020
medline: 18 11 2020
Statut: epublish

Résumé

Falls are two to four times more frequent amongst older adults living in long-term care (LTC) than community-dwelling older adults and have deleterious consequences. It is hypothesised that a progressive exercise program targeting balance and strength will reduce fall rates when compared to a seated exercise program and do so cost effectively. This is a single blind, parallel-group, randomised controlled trial with blinded assessment of outcome and intention-to-treat analysis. LTC residents (age ≥ 65 years) will be recruited from LTC facilities in New Zealand. Participants (n = 528 total, with a 1:1 allocation ratio) will be randomly assigned to either a novel exercise program (Staying UpRight), comprising strength and balance exercises designed specifically for LTC and acceptable to people with dementia (intervention group), or a seated exercise program (control group). The intervention and control group classes will be delivered for 1 h twice weekly over 1 year. The primary outcome is rate of falls (per 1000 person years) within the intervention period. Secondary outcomes will be risk of falling (the proportion of fallers per group), fall rate relative to activity exposure, hospitalisation for fall-related injury, change in gait variability, volume and patterns of ambulatory activity and change in physical performance assessed at baseline and after 6 and 12 months. Cost-effectiveness will be examined using intervention and health service costs. The trial commenced recruitment on 30 November 2018. This study evaluates the efficacy and cost-effectiveness of a progressive strength and balance exercise program for aged care residents to reduce falls. The outcomes will aid development of evidenced-based exercise programmes for this vulnerable population. Australian New Zealand Clinical Trials Registry ACTRN12618001827224. Registered on 9 November 2018. Universal trial number U1111-1217-7148.

Sections du résumé

BACKGROUND BACKGROUND
Falls are two to four times more frequent amongst older adults living in long-term care (LTC) than community-dwelling older adults and have deleterious consequences. It is hypothesised that a progressive exercise program targeting balance and strength will reduce fall rates when compared to a seated exercise program and do so cost effectively.
METHODS/DESIGN METHODS
This is a single blind, parallel-group, randomised controlled trial with blinded assessment of outcome and intention-to-treat analysis. LTC residents (age ≥ 65 years) will be recruited from LTC facilities in New Zealand. Participants (n = 528 total, with a 1:1 allocation ratio) will be randomly assigned to either a novel exercise program (Staying UpRight), comprising strength and balance exercises designed specifically for LTC and acceptable to people with dementia (intervention group), or a seated exercise program (control group). The intervention and control group classes will be delivered for 1 h twice weekly over 1 year. The primary outcome is rate of falls (per 1000 person years) within the intervention period. Secondary outcomes will be risk of falling (the proportion of fallers per group), fall rate relative to activity exposure, hospitalisation for fall-related injury, change in gait variability, volume and patterns of ambulatory activity and change in physical performance assessed at baseline and after 6 and 12 months. Cost-effectiveness will be examined using intervention and health service costs. The trial commenced recruitment on 30 November 2018.
DISCUSSION CONCLUSIONS
This study evaluates the efficacy and cost-effectiveness of a progressive strength and balance exercise program for aged care residents to reduce falls. The outcomes will aid development of evidenced-based exercise programmes for this vulnerable population.
TRIAL REGISTRATION BACKGROUND
Australian New Zealand Clinical Trials Registry ACTRN12618001827224. Registered on 9 November 2018. Universal trial number U1111-1217-7148.

Identifiants

pubmed: 31915043
doi: 10.1186/s13063-019-3949-4
pii: 10.1186/s13063-019-3949-4
pmc: PMC6950827
doi:

Types de publication

Clinical Trial Protocol Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

46

Subventions

Organisme : Health Research Council of New Zealand
ID : 18/414

Références

J Am Geriatr Soc. 1991 Feb;39(2):142-8
pubmed: 1991946
J Am Med Dir Assoc. 2011 Sep;12(7):535-40
pubmed: 21450250
J Am Med Dir Assoc. 2017 Nov 1;18(11):921-927
pubmed: 28916290
Lancet. 2013 Jan 5;381(9860):47-54
pubmed: 23083889
J Am Geriatr Soc. 2017 Nov;65(11):2480-2487
pubmed: 28755415
J Gerontol. 1994 Mar;49(2):M85-94
pubmed: 8126356
J Am Geriatr Soc. 2005 Apr;53(4):695-9
pubmed: 15817019
J Gerontol A Biol Sci Med Sci. 2017 May 1;72(5):669-675
pubmed: 27449140
PLoS One. 2009;4(5):e5521
pubmed: 19436724
J Am Geriatr Soc. 2012 Nov;60(11):2127-36
pubmed: 23110433
J Clin Epidemiol. 2010 Aug;63(8):e1-37
pubmed: 20346624
Phys Ther. 2009 Jun;89(6):569-79
pubmed: 19389792
JAMA. 2010 Jan 20;303(3):258-66
pubmed: 20085954
PLoS One. 2015 Jun 09;10(6):e0129098
pubmed: 26058056
Ann Intern Med. 1994 Sep 15;121(6):442-51
pubmed: 8053619
J Am Med Dir Assoc. 2015 Feb;16(2):149-54
pubmed: 25304179
Cochrane Database Syst Rev. 2018 Sep 07;9:CD005465
pubmed: 30191554
J Head Trauma Rehabil. 2017 May/Jun;32(3):168-177
pubmed: 27603766
J Am Geriatr Soc. 2004 Apr;52(4):524-31
pubmed: 15066066
Osteoporos Int. 2003 Jul;14(6):515-9
pubmed: 12730755
Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2015;22(6):755-61
pubmed: 25942388
Mov Disord. 2013 Sep 15;28(11):1520-33
pubmed: 24132840
J Am Med Dir Assoc. 2012 Feb;13(2):187.e1-6
pubmed: 21816682
J Am Med Dir Assoc. 2014 Aug;15(8):559-63
pubmed: 24825170
Neurology. 2017 Jul 25;89(4):336-342
pubmed: 28659421
Arch Gerontol Geriatr. 2013 May-Jun;56(3):407-15
pubmed: 23294998
IEEE J Biomed Health Inform. 2016 May;20(3):838-847
pubmed: 25850097
Med Sci Sports Exerc. 2015 Oct;47(10):2119-28
pubmed: 25668406
Aust N Z J Public Health. 2004 Apr;28(2):180-7
pubmed: 15233359
Injury. 2012 Nov;43(11):1821-6
pubmed: 22884759
Osteoporos Int. 2010 Jun;21(6):891-902
pubmed: 19924496
J Gerontol A Biol Sci Med Sci. 2013 Jul;68(7):820-7
pubmed: 23250001
J Neuroeng Rehabil. 2016 May 12;13(1):46
pubmed: 27175731
Mil Med. 1990 May;155(5):202-7
pubmed: 2114579

Auteurs

Lynne Taylor (L)

The University of Auckland, Faculty of Medical and Health Sciences, Auckland, New Zealand. lm.taylor@auckland.ac.nz.
Auckland University of Technology, Health and Rehabilitation Research Institute, Auckland, New Zealand. lm.taylor@auckland.ac.nz.

John Parsons (J)

The University of Auckland, Faculty of Medical and Health Sciences, Auckland, New Zealand.

Denise Taylor (D)

Auckland University of Technology, Health and Rehabilitation Research Institute, Auckland, New Zealand.

Elizabeth Binns (E)

Auckland University of Technology, Health and Rehabilitation Research Institute, Auckland, New Zealand.

Sue Lord (S)

Auckland University of Technology, Health and Rehabilitation Research Institute, Auckland, New Zealand.

Richard Edlin (R)

The University of Auckland, Faculty of Medical and Health Sciences, Auckland, New Zealand.

Lynn Rochester (L)

Institute of Neuroscience/Newcastle University Institute for Ageing, Clinical Ageing Research Unit, Campus for Ageing and Vitality, Newcastle University, Newcastle upon Tyne, UK.
Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.

Silvia Del Din (S)

Institute of Neuroscience/Newcastle University Institute for Ageing, Clinical Ageing Research Unit, Campus for Ageing and Vitality, Newcastle University, Newcastle upon Tyne, UK.

Jochen Klenk (J)

Institute of Epidemiology and Medical Biometry Ulm, Ulm University, Ulm, Germany.
Department of Geriatrics and Geriatric Rehabilitation, Robert-Bosch-Hospital, Stuttgart, Germany.
IB University of Applied Sciences Berlin, Study Center Stuttgart, Stuttgart, Germany.

Christopher Buckley (C)

Institute of Neuroscience/Newcastle University Institute for Ageing, Clinical Ageing Research Unit, Campus for Ageing and Vitality, Newcastle University, Newcastle upon Tyne, UK.

Alana Cavadino (A)

The University of Auckland, Faculty of Medical and Health Sciences, Auckland, New Zealand.

Simon A Moyes (SA)

The University of Auckland, Faculty of Medical and Health Sciences, Auckland, New Zealand.

Ngaire Kerse (N)

The University of Auckland, Faculty of Medical and Health Sciences, Auckland, New Zealand.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH